Form4.ai
Sign Up Sign In

Kalaris Therapeutics, Inc. (KLRS) Insider Trading

Kalaris Therapeutics, Inc. (KLRS) has 3 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 28, 2026.

Filings
3
Purchases
0
$0
Sales
0
$0
Insiders
3

Most active KLRS insiders

Bayko Liisa Ann
Chief Financial Officer
0 bought · 0 sold · July 20, 2026
$0
KEATING LAURIE
Director
0 bought · 0 sold · Aug. 3, 2026
$0
Vandekop Amy O'Leary
VP, Corporate Controller
0 bought · 0 sold · Aug. 28, 2026
$0

Latest KLRS Form 4 filings

Date Insider Value Shares Stake Pre-planned Links
Aug. 28, 2026 filed Aug. 27, 2026 Vandekop Amy O'Leary VP, Corporate Controller $0 10,000 0% No
💬
Aug. 3, 2026 filed Aug. 1, 2026 KEATING LAURIE Director $0 18,000 0% No
💬
July 20, 2026 Bayko Liisa Ann Chief Financial Officer $0 220,000 0% No
💬

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.

Get alerted when KLRS insiders trade

Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.

Start free